Supporting entrepreneurship and innovation in Europe
Technology Transfer : Converting Research
into Products for the Market
Technology Transfer is a strategic area for us. It can be defined as the process of transforming the results of research and development into marketable products and services. This transformation can take place through a number of means, in particular the collaboration between research organisations and industry, the licensing of intellectual property rights, and the creation of start-up businesses or university spin-out companies.
Although Technology Transfer seed investments in Europe are in the radar of some investors, academic research is often considered to be 'too new' or 'too high-risk' to be transferred out of the research laboratory and financed by the traditional investors. New discoveries and technologies may fail to realise their potential unless they become attractive to industry or downstream investors and this is where we aim to play an important role.
Although Technology Transfer seed investments in Europe are in the radar of some investors, academic research is often considered to be 'too new' or 'too high-risk' to be transferred out of the research laboratory and financed by the traditional investors. New discoveries and technologies may fail to realise their potential unless they become attractive to industry or downstream investors and this is where we aim to play an important role.
We seek to support financially sustainable Technology Transfer structures or funds. These intermediaries typically invest into projects or start-up companies, at proof of concept, pre-seed, seed, post-seed to A & B rounds, where the companies can be financed further by the normal Venture capital / Private equity investor.We may also provide feedback on the structuring of appropriate Technology Transfer instruments.
Since 2005, we have evolved towards being one of the main European investors providing guidance and cornerstone funding to players in this emerging market segment, notably K.U.Leuven/CD3 (Belgium), IP Group (UK), Chalmers Innovation Seed Fund (Göteborg, Sweden), the UMIP Premier Fund (Manchester, UK) and Karolinska Development (Sweden).
Since 2005, we have evolved towards being one of the main European investors providing guidance and cornerstone funding to players in this emerging market segment, notably K.U.Leuven/CD3 (Belgium), IP Group (UK), Chalmers Innovation Seed Fund (Göteborg, Sweden), the UMIP Premier Fund (Manchester, UK) and Karolinska Development (Sweden).
Expansion and lower mid-market operations contribute to balancing our portfolio by offsetting the higher risk that is usually inherent in early-stage investments.
How to contact us
- For Private Equity and Venture Capital teams raising funds
- For SMEs and entrepreneurs looking for finance
Debt products
Copyright ©
European Investment Fund 2013 – The European Investment Fund is not responsible for the content of external internet sites.